Cargando…
Functional Interaction between Acyl-CoA Synthetase 4, Lipooxygenases and Cyclooxygenase-2 in the Aggressive Phenotype of Breast Cancer Cells
The acyl-CoA synthetase 4 (ACSL4) is increased in breast cancer, colon and hepatocellular carcinoma. ACSL4 mainly esterifies arachidonic acid (AA) into arachidonoyl-CoA, reducing free AA intracellular levels, which is in contradiction with the need for AA metabolites in tumorigenesis. Therefore, the...
Autores principales: | Maloberti, Paula M., Duarte, Alejandra B., Orlando, Ulises D., Pasqualini, María E., Solano, Ángela R., López-Otín, Carlos, Podestá, Ernesto J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978721/ https://www.ncbi.nlm.nih.gov/pubmed/21085606 http://dx.doi.org/10.1371/journal.pone.0015540 |
Ejemplares similares
-
The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target
por: Orlando, Ulises D., et al.
Publicado: (2012) -
Regulatory mechanisms leading to differential Acyl-CoA synthetase 4 expression in breast cancer cells
por: Dattilo, Melina A., et al.
Publicado: (2019) -
Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer
por: Orlando, Ulises D., et al.
Publicado: (2015) -
Giardia fatty acyl-CoA synthetases as potential drug targets
por: Guo, Fengguang, et al.
Publicado: (2015) -
Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy
por: Rossi Sebastiano, Matteo, et al.
Publicado: (2019)